Prevalence of silent cerebral infarct at institutions that performed surveillance magnetic resonance imaging (MRI) examinations.
| Reference . | Number of Silent Cerebral Infarcts . | Total Number of Patients . | Prevalence . | Confidence Interval . |
|---|---|---|---|---|
| Abbreviations: CSSCD, Cooperative Study for Sickle Cell Disease | ||||
| CSSCD 4 | 58 | 266 | 21.8% | 16.8–26.8 |
| French Cohort 21 | 23 | 155 | 15% | 9.4–20.6 |
| London Cohort 22 | 16 | 64 | 25% | 14.4–35.6 |
| Cumulative numbers from CSSCD, French Cohort and London Cohort | 97 | 485 | 20% | 16.4–23.6 |
| Reference . | Number of Silent Cerebral Infarcts . | Total Number of Patients . | Prevalence . | Confidence Interval . |
|---|---|---|---|---|
| Abbreviations: CSSCD, Cooperative Study for Sickle Cell Disease | ||||
| CSSCD 4 | 58 | 266 | 21.8% | 16.8–26.8 |
| French Cohort 21 | 23 | 155 | 15% | 9.4–20.6 |
| London Cohort 22 | 16 | 64 | 25% | 14.4–35.6 |
| Cumulative numbers from CSSCD, French Cohort and London Cohort | 97 | 485 | 20% | 16.4–23.6 |